NIH Weekly Funding Opportunities and Policy Notices
Notice NOT-EB-17-008 from the NIH Guide for Grants and Contracts
Notice NOT-EB-17-007 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-CA-17-049 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. The purpose of this FOA is to promote research on fusion oncoproteins in childhood cancers. Specifically, this FOA targets the following area designated as a scientific priority by the Blue Ribbon Panel (BRP): Recommendation E. Intensify research on the major drivers of childhood cancers: Improve our understanding of fusion oncoproteins in pediatric cancer and use new preclinical models to develop inhibitors that target them. The goal of this FOA is to establish a consortium of collaborating research teams to advance our understanding of the biology and mechanisms of action of fusion oncoproteins in pediatric cancers, and to apply this knowledge towards developing targeted therapeutic approaches. Increased attention to this important but understudied field can help overcome existing barriers to progress and pave the way to novel therapeutic approaches with increased efficacy and fewer side effects than current options. The research teams comprising the Fusion Oncoproteins in Childhood Cancers (FusOnC2) Consortium will take a comprehensive approach to understanding the biology of fusion oncoproteins in childhood cancers and will use this information to inform strategies for therapeutic targeting.
Notice NOT-OD-17-097 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-DA-18-015 from the NIH Guide for Grants and Contracts. The purpose of this RFA is to promote research investigating the underlying mechanisms by which opioids including prescription drugs exacerbate HIV-associated neuropathic pain. Results from these studies may help obtain information for developing safe and effective treatments of neuropathic pain for HIV-infected patients exposed to opioids.
Funding Opportunity RFA-DA-18-014 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity is to identify genetic and epigenetic factors that affect the recovery of the CD4+ T cells in response to anti-retroviral therapy in HIV infected people who inject drugs infected
Notice NOT-HG-17-012 from the NIH Guide for Grants and Contracts
Notice NOT-AI-17-033 from the NIH Guide for Grants and Contracts
Funding Opportunity PA-17-452 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) encourages research project grants (R01) investigating the incidence, course, and outcomes of pregnancy among women with disabilities. Areas of interest also include studies to inform preconceptional and antenatal counseling and strategies for addressing barriers to prenatal care, and management of pregnancy, the puerperium, and the transition to parenthood in order to optimize outcomes for women with physical, intellectual and developmental, and/or sensory disabilities and their families. Applicants are encouraged to include women with disabilities and members of the community in the design and conduct of their research.
Funding Opportunity PA-17-451 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) encourages small research project grants (R03) investigating the incidence, course, and outcomes of pregnancy among women with disabilities. Areas of interest also include studies to inform preconceptional and antenatal counseling and strategies for addressing barriers to prenatal care, and management of pregnancy, the puerperium, and the transition to parenthood in order to optimize outcomes for women with physical, intellectual and developmental, and/or sensory disabilities and their families. Applicants are encouraged to include women with disabilities and members of the community in the design and conduct of their research.
Funding Opportunity PAR-17-453 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement is to solicit Research Center applications for the Point-of-Care Technologies Research Network (POCTRN). POCTRNs purpose is to drive the development and application of appropriate point of care technologies through collaborative efforts that merge scientific and technological capabilities with clinical need. The POCTRN Research Centers will create a national research network that works to build expertise in the development of integrated systems that address unmet clinical needs in point-of-care testing and treatment through the creation of multidisciplinary partnerships. This opportunity is open to existing POCTRN grantees as well as new applicants.
Funding Opportunity RFA-CA-17-029 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to establish an Academic-Industrial Partnership Program to develop new and/or validate existing technologies, methods, and assays for the capture and quantification of tumor associated cells, DNA, RNA, or exosomes in body fluids of patients with early stage disease or those at high risk; as well as distinguishing cancer from benign disease; or aggressive from indolent cancers. The precompetitive alliances with industry will harmonize and validate technologies, methods and assays associated with liquid biopsies.
Notice NOT-CA-17-077 from the NIH Guide for Grants and Contracts
Notice NOT-OH-17-011 from the NIH Guide for Grants and Contracts
Notice NOT-HD-17-020 from the NIH Guide for Grants and Contracts
Notice NOT-OD-17-098 from the NIH Guide for Grants and Contracts
Notice NOT-HD-17-016 from the NIH Guide for Grants and Contracts
Notice NOT-HL-17-530 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-NR-17-002 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement invites applications to establish NINR P20 Exploratory Centers. The P20 mechanism is used to support planning for new programs, expansion or modification of existing resources, and studies to explore various approaches to the development of interdisciplinary programs that offer potential solutions to problems of special significance to the mission of the NIH. The P20 may lead to Center sustainability and/or the ability to be funded through other specialized or comprehensive grants.
Funding Opportunity RFA-NR-17-003 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement invites applications to establish NINR P30 Center of Excellence. The P30 mechanism is used to support planning for new programs, expansion or modification of existing resources, and studies to explore various approaches to the development of interdisciplinary programs that offer potential solutions to problems of special significance to the mission of the NIH. The P30 may lead to Center sustainability and/or the ability to be funded through other specialized or comprehensive grants. The purpose of this program is to support NINR P30 Centers of Excellence to enhance interdisciplinary, biobehavioral research for scientists conducting research in multiple complex chronic conditions in human adult populations. This FOA is specifically designed with the intent to support the NINR Common Data Element (CDE) initiative.